The groundbreaking therapy of the medication represents a exciting development in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets dual pathways – GLP-1 and glucose-dependent https://tirzepatidepeptide363538.blogoxo.com/42409065/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment